Panbela Therapeutics, Inc.
PBLA · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $0 | $1 | $0 |
| Total Curr. Assets | $5 | $1 | $2 | $3 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $9 | $9 | $9 |
| Total NC Assets | $0 | $9 | $9 | $9 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5 | $9 | $11 | $12 |
| Liabilities | – | – | – | – |
| Payables | $11 | $14 | $9 | $10 |
| Short-Term Debt | $3 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $1 | $1 | $1 |
| Total Curr. Liab. | $20 | $17 | $11 | $12 |
| LT Debt | $3 | $3 | $3 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $3 | $3 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $23 | $20 | $14 | $17 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$147 | -$140 | -$133 | -$125 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $128 | $128 | $128 | $120 |
| Total Equity | -$18 | -$11 | -$3 | -$5 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5 | $9 | $11 | $12 |
| Net Debt | $6 | $4 | $4 | $3 |